2 doses of HPV vaccine may be as effective as 3 in preteens

04/30/2013 | MedicalDaily.com · Bloomberg

Girls ages 9 to 13 who received two doses of human papillomavirus vaccine six months apart had the same levels of antibodies against two HPV strains as 16- to 26-year-olds who were given three doses, Canadian researchers found. However, they noted that preteens in the three-dose schedule were more protected against the virus two years after taking the last shot compared with preteens who just had two doses. The findings appear in the Journal of the American Medical Association.

View Full Article in:

MedicalDaily.com · Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA